These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6367046)

  • 1. Biological activity of recombinant human interleukin-2 produced in Escherichia coli.
    Rosenberg SA; Grimm EA; McGrogan M; Doyle M; Kawasaki E; Koths K; Mark DF
    Science; 1984 Mar; 223(4643):1412-4. PubMed ID: 6367046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the biological properties of purified natural and recombinant human interleukin-2.
    Naruo K; Hinuma S; Kato K; Koyama M; Tada H; Shiho O; Tsukamoto K
    Biochem Biophys Res Commun; 1985 Apr; 128(1):257-64. PubMed ID: 3872661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the biological activities of human recombinant interleukin-2(125) and native interleukin-2.
    Doyle MV; Lee MT; Fong S
    J Biol Response Mod; 1985 Feb; 4(1):96-109. PubMed ID: 3920358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ; Yang J; Shu S; Rosenberg SA
    J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of murine interleukin-2 cDNA in E. coli and biological activities of recombinant murine interleukin-2.
    Kashima N; Matsui H; Yamasaki S; Kondo N; Hamuro J
    J Biochem; 1987 Oct; 102(4):715-24. PubMed ID: 3325499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte activation by recombinant interleukin-2 in ovarian cancer patients.
    Boyer PJ; Berek JS; Zighelboim J
    Obstet Gynecol; 1989 May; 73(5 Pt 1):793-7. PubMed ID: 2784847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cytolytic cells by pure recombinant human interleukin 2.
    Devos R; Plaetinck G; Fiers W
    Eur J Immunol; 1984 Nov; 14(11):1057-60. PubMed ID: 6437845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity.
    Fierro MT; Liao XS; Lusso P; Bonferroni M; Matera L; Cesano A; Lista P; Arione R; Forni G; Foa R
    Leukemia; 1988 Jan; 2(1):50-4. PubMed ID: 3257539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherent lymphokine-activated natural killer cells in normal and severe combined immunodeficiency mice: large granular lymphocytes with natural killer cell phenotype and high cytolytic activity.
    Chang HL; Zaroukian MH; Morrison MH; Esselman WJ
    Nat Immun Cell Growth Regul; 1989; 8(2):89-99. PubMed ID: 2788243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological functions of recombinant human interleukin-2.
    Liu XY; Yu JL; Zheng HD; Chen Y; Shen JF; Feng ZH; Chen ZC; You LF; Sun BH; Zhou YY
    Chin J Biotechnol; 1991; 7(1):25-31. PubMed ID: 1773013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
    Saijo N; Ozaki A; Ishihara J; Sakurai M; Sasaki Y; Takahashi H; Sano T; Hoshi A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1290-7. PubMed ID: 3488026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells.
    Mulé JJ; Smith CA; Rosenberg SA
    J Exp Med; 1987 Sep; 166(3):792-7. PubMed ID: 3498002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction, purification and biological activities of recombinant human interleukin-2 analogs.
    Boone T; Chazin V; Kenney W; Swanson E; Altrock B
    Dev Biol Stand; 1988; 69():157-68. PubMed ID: 3066670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level expression, purification, and renaturation of recombinant murine interleukin-2 from Escherichia coli.
    Guisez Y; Demolder J; Mertens N; Raeymaekers A; Plaetinck G; Robbens J; Vandekerckhove J; Remaut E; Fiers W
    Protein Expr Purif; 1993 Jun; 4(3):240-6. PubMed ID: 8390881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches for the high-level expression of human interleukin-2 cDNA in Escherichia coli.
    Sato T; Matsui H; Shibahara S; Kobayashi T; Morinaga Y; Kashima N; Yamasaki S; Hamuro J; Taniguchi T
    J Biochem; 1987 Feb; 101(2):525-34. PubMed ID: 3294818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activation of murine natural killer cell functions by human recombinant DNA interleukin 2.
    Sayers T; Rossiter H; Chung J; Hren A; Armerding D
    Immunobiology; 1985 Apr; 169(3):303-18. PubMed ID: 3922876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes.
    Arienti F; Sulé-Suso J; Melani C; Maccalli C; Belli F; Illeni MT; Anichini A; Cascinelli N; Colombo MP; Parmiani G
    Hum Gene Ther; 1994 Sep; 5(9):1139-50. PubMed ID: 7833372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ; Krosnick JA; Rosenberg SA
    J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
    J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.